DB18497InvestigationalCell transplant therapies
APR-2020 is a CD34+ cells that have been transduced in vitro with a lentiviral vector carrying a codon-optimized sequence for expressing the wild type RPS19 protein.
- Code names
- APR-2020
What you can answer from here — as of March 17, 2026
Which companies are running trials of APR-2020, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account